Meridian Clinical Research (Washington) - PPDS

Washington D.C., District of Columbia 20016

0 studies enrolling now · 1 studies all time

What they study most

SARS-CoV-2

Studies at this site

• Study to Evaluate the Safety, Reactogenicity, and Effectiveness of mRNA-1273.214 SARS-CoV-2 (COVID-19) Vaccine in Infants — Stopped early